KalVista Stock Falls After FDA Institutes Clinical Hold On Hereditary Angioedema Trial With KVD824

 

 

Related content: Benzinga's Full FDA Calendar



     

 

 

 

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.